Adverse effect | Early atropine DSE | Conventional DSE | |
---|---|---|---|
⩾70 years (n = 258) | <70 years (n = 258) | ⩾70 years (n = 290) | |
Data are number (%) of patients. | |||
*p<0.05 between patients ⩾70 and <70 years old in early atropine DSE; †p<0.05 between patients ⩾70 years in early atropine and conventional DSE. | |||
VT, ventricular tachycardia. | |||
Cardiac arrhythmias | |||
Ventricular extrasystoles | 67 (25.9%) | 60 (23.2%) | 105 (36.2%)† |
Supraventricular extrasystoles | 35 (13.6%) | 25 (9.7%) | 42 (14.5%) |
Non-sustained VT | 4 (1.6%) | 1 (0.4%) | 15 (5.2%)† |
Atrial fibrillation | 5 (1.9%) | 3 (1.2%) | 4 (1.3%) |
Symptomatic bradycardia | 0 | 2 (0.7%) | 6 (2.1%)† |
Chest pain | 26 (10.1%) | 23 (8.9%) | 38 (13.1%) |
Nausea | 1 (0.4%) | 4 (1.5%) | 7 (2.4%) |
Hypotension | 42 (16.2%) | 23 (9.6%)* | 66 (22.3%)† |
Symptomatic hypotension | 3 (1.2%) | 5 (1.9%) | 11 (3.7%)† |
Hypertension | 9 (3.5%) | 10 (3.9%) | 2 (0.7%)† |